During Kidney Month, American Kidney Fund Marks Its 50th Anniversary by Honoring Patient Milestones
ROCKVILLE, MD / ACCESSWIRE / March 1, 2021 / Fifty years ago, a small group of friends created a nonprofit...
News
Evotec and Chinook Therapeutics Enter Into Strategic Collaboration to Discover and Develop Novel Precision Medicines for Chronic Kidney Diseases
COLLABORATION WILL LEVERAGE THE NURTURE PATIENT BIOBANK AND EVOTEC'S MULTI-OMICS PLATFORMS PANHUNTER AND PANOMICS EVOTEC AND CHINOOK AIM TO CHARACTERISE...
Minerco Introduces Sean Kingston as the Company’s Newest Ambassador
The global sensation joins the company at a critical time with the upcoming launch of their blockchain token SHRU KINGSTON,...
BridgeBio Pharma and Affiliate Origin Biosciences Announce FDA Approval of NULIBRY™ (fosdenopterin), the First and Only Approved Therapy to Reduce the Risk of Mortality in Patients with MoCD Type A
Molybdenum cofactor deficiency (MoCD) Type A, an ultra-rare, life-threatening genetic disorder that progresses rapidly, results in severe and largely irreversible...
Annual financial report 2020
FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: Anne Sophie Pijcke, directeur, aspijcke@financiere-tubize.be Annual financial report...
Imara to Webcast Conference Call of Full Year 2020 Financial Results and Business Highlights
BOSTON, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing...
XPhyto Provides Updated Comments on Promotional and Marketing Activity
VANCOUVER, BC / ACCESSWIRE / February 26, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") at the request...
Therma Bright Enters into Clinical Trial Agreement for its AcuVid(TM) COVID-19 Rapid Saliva-Based Antigen Test
Toronto, Ontario--(Newsfile Corp. - February 26, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical...
Neutra Looking Into Medical and Recreational Cannabis Market as Legislative Outlook Improves
KATY, TX / ACCESSWIRE / February 26, 2021 / Neutra Corp. (OTC PINK:NTRR) ("Neutra" or "the Company") is considering a...
Havn Life Sciences to Host Investor Webcast on March 3, 2021
Attendees will have the opportunity to get the latest updates and participate in Q & A with Havn Life's CEO...
BioLife Sciences Inc. (OTCPK:BLFE) Announces the Launch of Their New Copper Infused Face Masks
Toronto, Ontario, Canada, Feb. 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife Sciences (OTCPK: BLFE) announces the launch of...
Supernus to Present at Cowen Healthcare Conference
ROCKVILLE, Md., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and...
Evolus Announces Promotion of Crystal Muilenburg to Chief Marketing Officer
NEWPORT BEACH, Calif., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq: EOLS), a performance beauty company with a customer-centric...
Innovation Pharma Provides Study Details for Ongoing Phase 2 Clinical Trial of Brilacidin in Hospitalized COVID-19 Patients
WAKEFIELD, Mass., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today provides...
No B.S. Skincare, A PureK Holdings Subsidiary, Announces Transition to All-New Sustainable Aluminum Packaging
Award-Winning Indie Brand Announces Step Forward in Sustainable PackagingMIAMI, Feb. 26, 2021 (GLOBE NEWSWIRE) -- PureK Holdings Corp. ("PureK") (TSX...
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion and Emergency Use Authorization Request
TORONTO, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty...
Peter Lougheed Centre Joins the Phase II Trial of LSALT Peptide for the Treatment of Complications in Hospitalized COVID-19 Patients
TORONTO, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF),...
Daxor Corporation Announces $0.48 Per Share NAV Increase and Files Annual Report for Fiscal 2020
Revenues of Operating Division Increase by 50.4% NEW YORK, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR)...
Albireo Spotlights Global Patient Communities on Rare Disease Day
– Calls to unite global communities affected by rare diseases – – Albireo supports increasing education and advances in research...
Novavax and Takeda Finalize License Agreement for Novavax’ COVID-19 Vaccine Candidate in Japan; Takeda Initiates Phase 1/2 Trial in Japan
Agreement includes COVID-19 vaccine technology transfer to Takeda for local manufacturing and commercialization in JapanTakeda doses first participant in immunogenicity...